A "TNM" classification system for cancer pain: The Edmonton Classification System for Cancer Pain (ECS-CP)

Supportive Care in Cancer

Volumn 16, Issue 6, 2008, Pages 547-555

  Fainsinger, Robin L ^a,b   Nekolaichuk, Cheryl L ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b GREY NUNS COMMUNITY HOSPITAL   (Canada)

Author keywords

Cancer pain; Classification system; Stable pain control

Indexed keywords

ANALGESIC AGENT; MORPHINE; OPIATE;

ACCURACY; BEHAVIOR; CANCER CLASSIFICATION; CANCER PAIN; CANCER PATIENT; CANCER STAGING; CLINICAL ASSESSMENT; COGNITION; CONSTRUCT VALIDITY; DISTRESS SYNDROME; DRUG DOSE ESCALATION; EDMONTON STAGING SYSTEM; HUMAN; INTERRATER RELIABILITY; PAIN ASSESSMENT; PALLIATIVE THERAPY; PREDICTIVE VALIDITY; PRIORITY JOURNAL; REVIEW;

HUMANS; NEOPLASMS; PAIN; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS;

EID: 44449104603     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-008-0423-3     Document Type: Review

References (46)

1. Agency for Health Care Policy and Research (1994) Management of cancer pain: adults. Am J Hosp Pharm 51:1643-1656
2. Arner S, Meyerson BA (1988) Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 33:11-23
3. Arner S (1998) Pain analysis in prediction of treatment outcome. Acta Anaesth Scand Suppl 113:24-28
4. Boisvert M, Cohen SR (1995) Opioid use in advanced malignant disease: why do different centres use vastly different doses? A plea for standardized reporting. J Pain Symptom Manage 10:632-638
5. Bruera E, Fainsinger R, Spachynski K et al (1995) Clinical efficacy and safety of a novel controlled-release morphine suppository and subcutaneous morphine in cancer pain: a randomized evaluation. J Clin Oncol 13:1520-1527
6. Bruera E, Macmillan K, Hanson J, MacDonald RN (1989) The Edmonton staging system for cancer pain: preliminary report. Pain 37:203-209
7. Bruera E, Moyano J, Seifert L, Fainsinger RL et al (1995) The frequency of alcoholism among patients with pain due to terminal cancer. J Pain Symptom Manage 10:599-603
8. Bruera E, Schoeller T, Wenk R et al (1995) A prospective multicenter assessment of the Edmonton staging system for cancer pain. J Pain Symptom Manage 10:348-355
9. Bruera E, Sloan P, Mount B et al (1996) A randomized, double-blind, double-dummy, crossover trial comparing the safety and efficacy of oral sustained-release hydromorphone with immediate-release hydromorphone in patients with cancer pain. Canadian Palliative Care Clinical Trials Group. J Clin Oncol 14:1713-1717
10. Bruera E, Watanabe S, Fainsinger RL et al (1995) Custom-made capsules and suppositories of methadone for patients on high-dose opioids for cancer pain. Pain 62:141-146
11. Caraceni A, Portenoy RK (1991) An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain 82:263-274
12. Caraceni A (1996) Clinicopathologic correlates of common cancer pain syndromes. Hematol Oncol Clin North Am 10:57-58
13. De Stoutz ND, Bruera E, Suarez-Almazor M (1995) Opioid rotation for toxicity reduction in terminal cancer patients. J Pain Symptom Manage 10:378-384
14. Ernst DS, Brasher P, Hagen N et al (1997) A randomized, controlled trial of intravenous clodronate in patients with metastatic bone disease and pain. J Pain Symptom Manage 13:319-326
15. Fainsinger RL, Lowe S, Nekolaichuk C, Lawlor P (2006) Is pain intensity predictive for complexity of Cancer Pain? Palliat Med 20(3):269
16. Fainsinger RL, Nekolaichuk CL, Lawlor PG, Neumann CM, Hanson J, Vigano A (2005) A multicentre validation study of the Revised Edmonton Staging System for classifying cancer pain in advanced cancer patients. J Pain Symptom Manage 29:224-237
17. Fainsinger RL, Nekolaichuk CL, Lawlor PG, Neumann CM. Edmonton classification system for cancer pain (ECS-CP). http://www.palliative.org/PC/ Clinicalinfo/AssessmentToolsIDX.html
18. Fainsinger RL, Toro R (1998) Opioids, confusion in opioid rotation. Palliat Med 12:463-464
19. Foley K (2000) Pain assessment and cancer pain syndromes. In: Doyle D, Hanks G, MacDonald N (eds) Oxford textbook of palliative medicine. Oxford University Press, Oxford, pp 310-331
20. Hanks G, Portenoy RK, MacDonald N et al (2000) Difficult pain problems. In: Doyle D, Hanks G, MacDonald N (eds) Oxford textbook of palliative medicine. Oxford University Press, Oxford, pp 454-477
21. Hwang S, Chang V, Kasimis B (2003) Cancer breakthrough pain characteristics and responses to treatment at VA Medical Centre. Pain 101:55-64
22. Hwang SS, Chang VT, Fairclough DL et al (2002) Development of a cancer pain prognostic scale. J Pain Symptom Manage 24(4):366-378
23. Jadad AR, Carroll D, Glynn CJ et al (1992) Morphine responsiveness of chronic pain: double-blind randomized crossover study with patient-controlled analgesia. Lancet 339:1367-1371
24. Kaiko RF, Wallenstein SL, Rogers AG et al (1982) Narcotics in the elderly. Med Clin North Am 66:1079-1089
25. Lawlor P, Walker P, Bruera E et al (1997) Severe opioid toxicity and somatization of psychosocial distress in a cancer patient with a background of chemical dependence. J Pain Symptom Manage 13:356-361
26. Levy MH (1996) Pharmacologic treatment of cancer pain. New Engl J Med 335:1124-1132
27. Lowe S, Nekolaichuk C, Fainsinger R, Lawlor P (2008) Should the rate of opioid dose escalation be included as a factor in a Cancer Pain Classification System? J Pain Symptom Manage 35(1):51-57
28. Lutfy K, Yoburn BC (1991) The role of opioid receptor density in morphine tolerance. J Pharmacol Exp Ther 256:575-580
29. Mercadante S, Casuccio A, Pumo S et al (2000) Factors influencing the opioid response in advanced cancer patients with pain followed at home: The effects of age and gender. Support Care in Cancer 8:123-130
30. Mercadante S, Fulfaro F, Casuccio A et al (1999) Investigation of an opioid response categorization in advanced cancer patients. J Pain Symptom Manage 18:347-352
31. Nekolaichuk C, Fainsinger R, Lawlor P (2005) A validation study of a pain classification system for advanced cancer patients using content experts: the Edmonton classification system for cancer pain. Palliat Med 19(6):466-476
32. Otis-Green S, Sherman R, Perez M et al (2002) An integrated psychosocial-spiritual model for cancer pain management. Cancer Pract 10(suppl 1):S58-S64
33. Passik SD, Portenoy RK, Ricketts PL (1998) Substance abuse issues in cancer patients. Part 1: Prevalence and diagnosis. Oncology 12:517-521
34. Passik SD, Portenoy RK, Ricketts PL (1998) Substance abuse issues in cancer patients. Part 2: Evaluation and treatment. Clin Tech Small Anim Pract 13:65-69
35. Passik SD, Theobald DE (2000) Managing addiction in advanced cancer patients: why bother? J Pain Symptom Manage 19:229-234
36. Piccirillo OJ, Feinstein A (1996) Clinical symptoms and co-morbidity: significance for the prognostic classification of cancer. Cancer 77:834-842
37. Portenoy RK, Foley KM, Inturrisi CE (1990) The nature of opioid responsiveness and its implications for neuropathic pain: new hypotheses derived from studies of opioid infusions. Pain 43:273-286
38. Portenoy RK, Lesage P (1999) Management of cancer pain. Lancet 353:1695-1700
39. Portenoy RK, Payne D, Jacobsen P (1999) Breakthrough pain: characteristics and impact in patients with cancer pain. Pain 81:129-134
40. Sellers AH (1971) The clinical classification of malignant tumors: the TNM system. CMAJ 105:836-843
41. South SM, Smith MT (2001) Analgesic tolerance to opioids. Pain 9(5):1-4
42. Sutton LM, Porter LS, Keefe FJ (2002) Cancer pain at the end of life: a biopsychosocial perspective. Pain 99:5-10
43. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F (1987) A validation study of the WHO method for cancer pain relief. Cancer 59:850-56
44. Woolf CJ, Decosterd I (1999) Implications of recent advances in the understanding of pain pathophysiology for the assessment of pain in patients. Pain Suppl 6:S141-S147
45. Zaza C, Baine N (2002) Cancer pain and psychosocial factors: a critical view of the literature. J Pain Symptom Manage 24:526-542
46. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA (1995) Validation of the World Health Organization guidelines for cancer pain relief: a 10-year retrospective study. Pain 63:65-76